Premenstrual Syndrome Clinical Trials

Find Premenstrual Syndrome Clinical Trials Near You

To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The aim of this project is to compare the ovarian hormone levels 7 days after ovulation and progesterone:oestradiol ratios between PMDD individuals and a control cohort (case control study).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Aged 18-45 years old (adults but less than the typical perimenopausal age so there is not added bias/variable)

• Regular menstrual cycles (21-35 days for the last 3 months)

• Willing and able to complete a questionnaire (no new clinical diagnosis given)

• Use home urine LH test strips to detect ovulation

• Attend a single in person on site in Lancaster mid luteal blood test sample appointment (approx 7 days post LH surge)

• Provide written informed consent

• Have sufficient English language skills to understand the patient information

• Be either in Group 1 or group 2 Group 1 (PMDD group ie case group) - self reported prior diagnosis of PMDD made by a healthcare professional (GP, psychiatrist, gynaecologist) Group 2 (Control group ie comparison group) - no prior diagnosis of PMDD made by a healthcare professional and no history of clinically significant premenstrual mood symptoms on screening

Locations
Other Locations
United Kingdom
Lancaster University
RECRUITING
Lancaster
Contact Information
Primary
Milli Raizada, MBCHB Hons
m.raizada2@lancaster.ac.uk
+44 (0)1524 65201
Time Frame
Start Date: 2026-05-05
Estimated Completion Date: 2027-08-01
Participants
Target number of participants: 50
Treatments
control group
oestrogen and progesterone levels and ratios 5-7 days post ovulation
PMDD group
oestrogen and progesterone levels and ratios 5-7 days post ovulation
Sponsors
Leads: Lancaster University

This content was sourced from clinicaltrials.gov